Gene transfer as a tool to induce therapeutic vascular growth in plastic surgery

Handchirurgie Mikrochirurgie Plastische Chirurgie

Volumn 37, Issue 6, 2005, Pages 375-382

  Saaristo, Anne ^a,b,c,e   Suominen, E ^c   Yla Herttuala, S ^d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Flap; Ischemia; Lymphangiogenesis; Lymphedema

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CYSTEINE RICH PROTEIN 61; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 5; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TISSUE KALLIKREIN; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; EDEMA; GENE TRANSFER; GRAFT SURVIVAL; HUMAN; ISCHEMIA; ISCHEMIC HEART DISEASE; LYMPHANGIOGENESIS; PLASTIC SURGERY; REVIEW; TISSUE PERFUSION; WOUND HEALING;

ANIMALS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; LYMPHANGIOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SURGICAL FLAPS; TISSUE SURVIVAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 29944441029     PISSN: 07221819     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872984     Document Type: Review

References (89)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K. Stacker SA: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998; 95: 548-553
2. Ashrafpour H, Huang N, Neligan PC, Forrest CR, Addison PD, Moses MA, Levine RH, Pang CY: Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol 2004; 286: H949-H954
3. Banbury J, Siemionow M, Porvasnik S, Petras S, Browne E: Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000; 106: 1541-1546
4. Bates DO, Jones RO: The role of vascular endothelial growth factor in wound healing. Int J Low Extrem Wounds 2003; 2: 107-120
5. Baumeister RG, Siuda S, Bohmert H, Moser E: A microsurgical method for reconstruction of interrupted lymphatic pathways: Autologous lymph-vessel transplantation for treatment of lymphedemas. Scand J Plast Reconstr Surg 1986; 20: 141-146
6. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-1379
7. Campisi C, Boccardo F: Microsurgical techniques for lymphedema treatment: Derivative lymphatic-venous microsurgery. World J Surg 2004; 28: 609-613
8. Carmeliet P: VEGF gene therapy: Stimulating angiogenesis or angioma-genesis? Nat Med 2000; 6: 1102-1103
9. Clark RA: Cutaneous tissue repair: Basic biologic considerations. IJ Am Acad Dermatol 1985; 13: 701-725
10. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Raziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169
11. Dumont DJ, Gradwohl G, Fong G-H, Pun MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8: 1897-1909
12. Frank S, Hübner G, Breier G, Longager MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes.J Biol Chem 1995; 270: 12607-12613
13. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002; 3: 411-423
14. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F: Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46: 546-555
15. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC: Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164: 1935-1947
16. Gerhardt H, Betsholtz C: Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003; 314: 15-23
17. Giunta RE, Holzbach T, Taskov C, Holm PS, Konerding MA, Schams D, Biemer E, Gänsbacher B: AdVEGF165 gene transfer increases survival in overdimensioned skin flaps. J Gene Med 2005; 7: 297-306
18. Gleadle JM, Ratcliffe PJ: Hypoxia and the regulation of gene expression. Mol Med Today 1998; 4: 122-129
19. Grazul-Bilska AT, Johnson ML, Bilski JJ, Redmer DA, Reynolds LP, Abdullah A, Abdullah KM: Wound healing: The role of growth factors. Drugs Today 2003; 39: 787-800
20. Gurunluoglu R, Lubiatowski P, Goldman CK, Carnevale K, Siemionow M: Enhancement of muscle flap hemodynamics by angiopoietin-1. Ann Plast Surg 2003; 48: 401-409
21. Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M: Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann Plast Surg 2002; 49: 161-169
22. Hickey MJ, Wilson Y, Hurley JV, Morrison WA: Mode of vascularization of control and basic fibroblast growth factor-stimulated prefabricated skin flaps. Plast Reconstr Surg 1998; 101: 1296-1304
23. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998
24. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV, Sheppard D: Fatal bilateral chylothorax in mice lacking the integrin a9b1. Mol Cell Biol 2000; 20: 5208-5215
25. Huemer GM, Meirer R, Gurunluoglu R, Kamelger FS, Dunst KM, Wanner S, Piza-Katzer H: Comparison of the effectiveness of gene therapy with transforming growth factor-beta or extracorporeal shock wave therapy to reduce ischemic necrosis in an epigastric skin flap model in rats. Wound Repair Regen 2005; 13: 262-268
26. Im MJ, Kim YS, Edwards R, Hoopes JE, Fenselau A: The effect of bovine basic fibroblast growth factor on skin flap survival in rats. Ann Plast Surg 1992; 28: 242-245
27. Ishiguro N, Yabe Y, Shimizu T, Iwata H, Miura T: Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 1994; 32: 356-360
28. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W: Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80: 829-837
29. Javerzat S, Auguste P, Bikfalvi A: The role of fibroblast growth factors in vascular development. Trends Mol Med 2002; 10: 483-489
30. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298
31. Jung H, Gurunluoglu R, Scharpf J, Siemionow M: Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery 2003; 23: 374-380
32. Kane AJ, Barker JE, Mitchell GM, Theile DR, Romero R, Messina A, Wagh M, Fraulin FO, Morrison WA, Stewart AG: Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2001; 132: 1631-1638
33. Karkkainen MJ, Petrova TV: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000; 19: 5598-5605
34. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Ylä-Herttuala S, Finegold DN, Ferrell RE, Alitalo K: A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001; 98: 12677-12682
35. Kerringan CL: Skin flap failure: Pathophysiology. Plast Rec Surg 1983; 6: 766-777
36. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC, Shaw WW: The effect of basic fibroblast growth factor on the neovascularisation process: skin flap survival and staged flap transfers. Br J Plast Surg 1991; 44: 585-588
37. Kim I, Kwak HJ, Ahn JE, So JN, Liu M, Koh KN, Koh GY: Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett 1999; 443: 353-356
38. Komorowska-Timek E, Timek TA, Brevetti LS, Zhang F, Lineaweaver WC, Buncke HJ: The effect of single administration of vascular endothelial growth factor or L-arginine on necrosis and vasculature of the epigastric flap in the rat model. Br J Plast Surg 2004; 57: 317-325
39. Kryger Z, Dogan T, Zhang F, Komorowska-Timek E, Shi DY, Cheng C, Lineaweaver WC, Buncke HJ: Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999; 43: 172-178
40. Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K: Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA 2002; 99: 8868-8873
41. Lantieri LA, Martin-Garcia N, Wechsler J, Mitrofanoff M, Raulo Y, Baruch JP: Vascular endothelial growth factor expression in expanded tissue: A possible mechanism of angiogenesis in tissue expansion. Plast Rec Surg 1998; 101: 392-398
42. Lehrman S: Virus treatment questioned after gene therapy death. Nature 1999; 401: 517-518
43. Lineaweaver WC, Lei MP, Mustain W, Oswald TM, Cui D, Zhang F: Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg 2004; 239: 866-873
44. Liu PY, Wang XT, Badiavas E, Rieger-Christ K, Tang JB, Summerhayes I: Enhancement of ischemic flap survival by prefabrication with transfer of exogenous PDGF gene. J Reconstr Microsurg 2005; 21: 273-279
45. Lubiatowski P, Goldman C, Gurunluoglu R, Carnevale K, Siemionow M: Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Rec Surg 2002; 109: 1986-1993
46. Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M: Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast Rec Surg 2002; 110: 149-159
47. Machens HG, Morgan JR, Berthiaume F, Stefanovich P, Siemers F, Krapohl B, Berger A, Mailänder P: Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent. Surgery 2002; 131: 393-400
48. Maisonpierre PC, Sun C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60
49. Morishita R, Aoki M, Hashiya N, Yamasaki K, Kurinami H, Shimizu S, Makino H, Takesya Y, Azuma J, Ogihara T: Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 2004; 4: 199-206
50. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA: Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452
51. O'Toole G MD, Lindeman R, Buckley MF, Marucci D, McCarthy N, Poole M: Vascular endothelial growth factor gene therapy in ischaemic rat skin flaps. Br J Plast Surg 2002; 55: 55-58
52. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K: Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000; 156: 1499-1504
53. Pajusola K, Kunnapuu J, Vuorikoski S, Soronen J, Andre H, Pereira T, Korpisalo P, Ylä-Herttuala S, Poellinger L, Alitalo K: Stabilized HIF-1 alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 2005; 19: 1365-1367
54. Pang CY, Forrest CR, Neligan PC, Lindsay WK: Augmentation of blood flow in delayed random skin flaps in the pig: Effect of length of delay period and angiogenesis. Plast Rec Surg 1986; 78: 68-74
55. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K: VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000; 14: 2087-2096
56. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, Miura N, Alitalo K: Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004; 10: 974-981
57. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848
58. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J: The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 1995; 14: 5884-5891
59. Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS: Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 2001; 8: 523-533
60. Risau W, Flamme I: Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91
61. Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I, Jauhiainen S, Cashion L, Gruchala M, Narvanen O, Taipale P, Kauppinen RA, Rubanyi GM, Yla-Herttuala S: Fibroblast growth factor-4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 2003; 17: 100-102
62. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholova I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Yla-Herttuala S: VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 2003; 92: 1098-1106
63. Romano Di Peppe S, Mangoni A, Zambruno G, Spinetti G, Melillo G, Napolitano M, Capogrossi MC: Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 2002; 9: 1271-1277
64. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A, Hedman A, Hedman M, Heikura T, Orden MR, Stacker SA, Achen MG, Hartikainen J, Yla-Herttuala S: Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 2004; 109: 1029-1035
65. Saaristo A, Tammela T, Timonen J, Yla-Hemuala S, Tukiainen E, Asko-Seljavaara S, Alitalo K: Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J 2004; 18: 1707-1709
66. Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Yla-Herttuala S, Alitalo K: Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 2002; 196: 719-730
67. Scalise A, Tucci MG, Lucarini G, Giantomassi F, Orlando F, Pierangeli M, Pugnaloni A, Bertani A, Ricotti G, Biagini G: Local rh-VEGF administration enhances skin flap survival more than other types of rh-VEGF administration: a clinical, morphological and immunohistochemical study. Exp Dermatol 2004; 13: 682-690
68. Schwentker A, Vodovotz Y, Weller R, Billiar TR: Nitric oxide and wound repair: Role of cytokines? Nitric Oxide 2002; 7: 1-10
69. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 842-845
70. Storkebaum E, Lambrechts D, Carmeliet P: VEGF: Once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004; 26: 943-954
71. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG: Therapeutic lymphangiogenesis with VEGF-C. FASEB J 2002; 16: 1985-1987
72. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438
73. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM: Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995; 147: 1649-1660
74. Tammela T, Enholm B, Alitalo K, Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65: 550-563
75. Tammela T, Saaristo A, Lohela M, Morisada T, Tornberg J, Norrmen C, Oike Y, Pajusola K, Thurston G, Suda T, Yla-Herttuala S, Alitalo K: Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 2005; 105: 4642-4648
76. Thurston G, Suri C Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511-2514
77. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, Copeland NG, Gilbert DJ, Jenkins NA, Huang T, Papadopoulos N, Maisonpierre PC, Davis S, Yancopoulos GD: Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 1999; 96: 1904-1909
78. Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K: Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001; 6: 1223-1231
79. Vincent KA, Shyu KG, Luo YX, Magner M, Tio RA, Jiang CW, Goldberg MA, Akita GY, Gregory RJ, Isner JM: Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1 alpha/ VP16 hybrid transcription factor. Circulation 2000; 102: 2255-2261
80. Wigle JT, Oliver G: Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-778
81. Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, Schlingemann RO: VEGFR-3 in adult angiogenesis. J Pathol 2001; 195: 490-497
82. Witte MH, Witte CL: Lymphangiogenesis and lymphologic syndromes. Lymphology 1986; 19: 21-28
83. Yamauchi A, Ito Y, Morikawa M, Kobune M, Huang J, Sasaki K, Takahashi K, Nakamura K, Dehari H, Niitsu Y, Abe T, Hamada H: Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 2003; 5: 994-1004
84. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM: Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411
85. Yla-Herttuala S, Alitalo K: Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701
86. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW: VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003; 111: 717-725
87. Zhang F, Yang F, Hu EC, Sones W, Lei M, Lineaweaver WC: Vascular endothelial growth factor gene therapy in improvement of skin paddle survival in a rat TRAM flap model. J Reconstr Microsurg 2005; 21: 391-396
88. Ziche M, Morbidelli L: Nitric oxide and angiogenesis. J Neurooncol 2000; 50: 139-148
89. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R: Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000; 49: 1451-1458